Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)

Pall Corporation

Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies

James Barry, Director of Marketing, Americas, Pall Biotech

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification

View All Featured Articles

Headline News

Lunsumio plus lenalidomide improves progression free survival in Phase III follicular lymphoma trial

CHMP recommends EU approval of FREHEMGO as the first factor VIIIa mimetic to offer monthly, biweekly, and weekly dosing through a pre-filled pen for haemophilia A treatment

Novo Nordisk’s CagriSema outperforms tirzepatide on weight loss in REIMAGINE 5 trial

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Making continuous processing a reality in the pharmaceutical industry

Presented by Mark Gibson Associate Director, Drug Product Manufacture & Delivery for AstraZeneca and Marcel de Matas, Principal Scientist at AstraZeneca
21st August 2013

Integrity Assurance for Single-Use Systems: End-User Perspective

Presented by Charlotte Masy, Senior Manager in Manufacturing Science and Technology GSK vaccines and Patrick Evrard, Senior Principal Engineer, Single-Use Technologies in Technical Communication and Regulatory Strategy, Pall Corporation
06th October 2021

Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos